SOM
Somnomed Ltd
Healthcare Equipment and Supplies
·
Healthcare
1
comment
1
fund manager
past 90 days
About Somnomed Ltd
SomnoMed Ltd., founded in 2004 and headquartered in Sydney, Australia, specializes in developing and distributing oral devices for treating sleep-related disorders. The company’s product portfolio includes SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and the Sunrise Sleep Test. SomnoMed operates globally, managing business segments across North America, Europe, and the Asia Pacific region. The firm provides medical technology solutions focused on the clinical management of obstructive sleep apnea and related sleep conditions.
Commentary Volume
1
Comments
1
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$122M
Fund managers
1 manager
First covered
31 Mar 2026
Last updated
31 Mar 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Somnomed Ltd (ASX:SOM)
Frequently asked questions
Who is investing in Somnomed Ltd (ASX:SOM)?
Fund managers including NAOS Asset Management have invested in Somnomed Ltd (ASX:SOM).
What is the short interest in Somnomed Ltd (ASX:SOM)?
According to ASIC filings, there is negligible or no short interest in Somnomed Ltd (ASX:SOM).
What does Somnomed Ltd (ASX:SOM) do?
SomnoMed Ltd., founded in 2004 and headquartered in Sydney, Australia, specializes in developing and distributing oral devices for treating sleep-related disorders. The company’s product portfolio includes SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and the Sunrise Sleep Test. SomnoMed operates globally, managing business segments across North America, Europe, and the Asia Pacific region. The firm provides medical technology solutions focused on the clinical management of obstructive sleep apnea and related sleep conditions.
Loading...